Tempus AI, Inc. (TEM) Gets FDA 510(k) OK for ECG-MR AI
Tempus AI, Inc. received FDA 510(k) clearance for Tempus ECG-MR, software that analyzes 12-lead ECGs to flag signs associated with undiagnosed moderate or severe mitral regurgitation in at-risk patients 65+.Material DetailsContext by AI AnalystThis is a continuation of Tempus’ push to build a regul…